Osimertinib: Another medication related to osteonecrosis of the jaws? A case report and literature review

Introduction: Medication-related osteonecrosis of the jaw (MRONJ) is an oral complication in cancer patients being treated with either antiresorptives, mainly denosumab and bisphosphonates, or antiangiogenic drugs. Osimertinib is a third-generation epidermal growth factor receptor (EGFR)-tyrosine ki...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feng, Wei, Shengnan, Zhang, Zexuan, Zhang, Yuan, He, Jingya, Sun, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400918/
https://www.ncbi.nlm.nih.gov/pubmed/36034820
http://dx.doi.org/10.3389/fphar.2022.947947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400918/
https://www.ncbi.nlm.nih.gov/pubmed/36034820
http://dx.doi.org/10.3389/fphar.2022.947947

Ejemplares similares